Boothbay Fund Management, LLC Aeterna Zentaris Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$0.34 - $0.55 $8,180 - $13,232
-24,059 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$0.77 - $1.08 $28,664 - $40,205
-37,227 Reduced 60.74%
24,059 $22,000
Q2 2019

Aug 14, 2019
BUY
$2.04 - $5.43 $31,483 - $83,801
15,433 Added 33.66%
61,286 $181,000
Q4 2018

Feb 14, 2019
BUY
$1.3 - $3.87 $59,608 - $177,451
45,853 New
45,853 $135,000

About Aeterna Zentaris Inc.

AEZS Quotes by TradingView
  • Ticker AEZS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,855,880
  • Market Cap $19.4M
  • Description
  • Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...
More about AEZS
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email